China's Military Imposes Stricter Procurement Rules on Healthcare Units

The Central Military Commission Logistic Support Department has issued new regulatory measures to strengthen anti-corruption governance across the military medical and healthcare system, according to the PLA Daily. The initiative introduces volume-based centralized procurement for low-value medical consumables and combat-readiness pharmaceuticals, establishing a tiered purchasing model led by Joint Logistics regions. The rules mandate strict execution of centralized procurement outcomes, ban unauthorized ad-hoc purchasing, require collective expert committee reviews for major medical equipment, and call for enhanced joint civil-military oversight.

Tightening procurement protocols in the military healthcare system directly impacts defense logistics spending efficiency and the quality of combat-ready medical supplies. By instituting transparent volume-based purchasing and collective review requirements, the Central Military Commission aims to eliminate illicit kickbacks and commercial bribery in the pharmaceutical and medical equipment supply chain.

The Central Military Commission Logistic Support Department has introduced comprehensive regulatory measures to deepen integrity and anti-corruption governance across the Chinese military's medical and healthcare system, according to a report published by the PLA Daily. The new directives mandate volume-based centralized procurement for low-value medical consumables and combat-readiness pharmaceuticals. Under the framework, procurement will be primarily organized across Joint Logistics regions, supplemented by coalition purchasing among medical facilities, with all-military centralized procurement serving as a secondary backstop. Military medical institutions are required to participate fully in centralized purchasing and strictly abide by both national and military-level procurement outcomes as well as local open-bidding results. The policy sets strict restrictions on discretionary or emergency purchasing of medicines and medical consumables. Authorities announced targeted investigations and disciplinary crackdowns against systemic procurement malpractices, including failing to report accurate demand volumes, avoiding mandated centralized catalogs, procuring only high-priced alternatives, and arbitrarily selecting unauthorized suppliers. Beyond consumables, the department is tightening oversight on major medical equipment allocation. Medical institutions must rely on collective evaluations conducted by specialized professional committees to justify equipment procurement and pharmaceutical selections, explicitly prohibiting unilateral administrative sign-offs or unauthorized equipment imports. Proposed medical equipment will also undergo operational requirement evaluations and corruption risk assessments to prevent the procurement of obsolete, unnecessary, or monopolized high-cost technologies. The regulatory push incorporates digital intelligence tools to monitor critical decision-making nodes, personnel in key posts, and approval procedures. Furthermore, the military plans to deepen cross-sector collaborative governance with civilian authorities to address entrenched issues in pharmaceutical sales, financial management, and clinical services.